Targeted Strategies for Today's Evolving Markets

MissionIR Blog

AxoGen, Inc. (AXGN) Starts Presentation at Dawson James Conference

AxoGen, Inc. (NASDAQ: AXGN) is a medical technology company dedicated to peripheral nerve repair. The company’s portfolio of regenerative medicine products is available in the United States, Canada and several other countries and includes Avance® Nerve Graft, for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard® Nerve Connector, for tensionless repair of severed nerves; and AxoGuard® Nerve Protector, a product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. For more information, visit the company’s website at

This entry was posted in Dawson James Conference. Bookmark the permalink.

Comments are closed.